Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Lewisville, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Lewisville, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Mesquite, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Paris, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Paris, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Round Rock, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Round Rock, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
San Antonio, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Southlake, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Southlake, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Sugar Land, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Waco, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Waco, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Webster, TX
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Christiansburg, VA
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Christiansburg, VA
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Seattle, WA
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Health Literacy Interventions to Overcome Disparities in CRC Screening
Health Literacy Interventions to Overcome Disparities in CRC Screening
Status: Enrolling
Updated:  3/5/2018
LSU Health Sciences Center
mi
from
Shreveport, LA
Health Literacy Interventions to Overcome Disparities in CRC Screening
Health Literacy Interventions to Overcome Disparities in CRC Screening
Status: Enrolling
Updated: 3/5/2018
LSU Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Sunitinib and Capecitabine for First Line Colon Cancer
A Single-Center, Phase II Trial of Sunitinib and Capecitabine in First Line Treatment of Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  3/6/2018
Lombardi Cancer Center-Georgetown University
mi
from
Washington,
Sunitinib and Capecitabine for First Line Colon Cancer
A Single-Center, Phase II Trial of Sunitinib and Capecitabine in First Line Treatment of Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 3/6/2018
Lombardi Cancer Center-Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation for High-Risk Lymphoma and Myeloma
Status: Enrolling
Updated:  3/8/2018
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation for High-Risk Lymphoma and Myeloma
Status: Enrolling
Updated: 3/8/2018
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling
Updated:  3/8/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling
Updated: 3/8/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling
Updated:  3/8/2018
Evanston CCOP-NorthShore University HealthSystem
mi
from
Evanston, IL
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling
Updated: 3/8/2018
Evanston CCOP-NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Tucson, AZ
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Beverly Hills, CA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Deer Park, CA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Deer Park, CA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Monterey, CA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Monterey, CA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Newport Beach, CA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Pomona, CA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Pomona, CA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Santa Rosa, CA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Soquel, CA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Soquel, CA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Stockton, CA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Stockton, CA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Colorado Springs, CO
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Greeley, CO
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Greeley, CO
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Middletown, CT
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Middletown, CT
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Norwich, CT
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Norwich, CT
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Aventura, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Aventura, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Coral Springs, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lake City, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lake City, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Miami, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Ormond Beach, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Sebastian, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Sebastian, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Vero Beach, FL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Augusta, GA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lawrenceville, GA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Marietta, GA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Galesburg, IL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Galesburg, IL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Park Ridge, IL
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Louisville, KY
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lafayette, LA
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lafayette, LA
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Grand Rapids, MI
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Kalamazoo, MI
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Branson, MO
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Branson, MO
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Billings, MT
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Billings, MT
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Great Falls, MT
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Great Falls, MT
Click here to add this to my saved trials
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated:  3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Albany, NY
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Status: Enrolling
Updated: 3/12/2018
AOI Pharmaceuticals Investigative Site
mi
from
Albany, NY
Click here to add this to my saved trials